Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

About the study

The purpose of this research study is to document and understand the effects of hydroxyurea
exposure for women with SCD and their babies, during both gestation and lactation.

Study point of contact

Teresa Latham
513-803-7922
[email protected]

Locations

1 United States site

Study type

Observational

Gender

All

Interventions

Other

Compensation

Unknown

participation requirements

– Medical records or data available from previous clinical care prior to June 20, 2019
of pregnant females with SCD, including women who miscarried, had a still birth, or
completed labor at any gestational stage, with any hydroxyurea exposure during either
pregnancy and/or while breastfeeding.

– Medical records or data available from previous clinical care prior to June 20, 2019
about pregnancy and breastfeeding outcomes, both for babies with hydroxyurea exposure
and other babies by these same women.

participation restrictions

– Unavailable medical records or lack of information about hydroxyurea exposure.

Locations

  • Cincinnati, Ohio, United States, Cincinnati Children's Hospital Medical Center, 45229 [Recruiting]
Last updated 2020-12-23